Marne La Vallee Cedex 3, France
81 employees
Founded 1968
Verified active February 2, 2026

Key Highlights

  • Cryopal's innovative solutions for liquid oxygen therapy and cryopreservation have been trusted by healthcare providers and research institutions for over 50 years.
  • The company's commitment to quality and customer satisfaction has established it as a key player in the health and medical research sectors.
  • Cryopal's extensive experience and expertise in its field make it a reliable partner for organizations seeking advanced solutions.
  • The company's focus on innovation and operational excellence ensures it remains at the forefront of its industry.
  • Cryopal's ability to adapt to changing market needs and its dedication to continuous improvement make it a valuable partner for long-term success.

About CRYOPAL

Cryopal has been a leading provider of innovative solutions for liquid oxygen therapy and cryopreservation of biological samples for over 50 years. The company specializes in serving the health and medical research sectors, pharmaceutical industry, genetics, and animal health. Based in Marne La Vallee Cedex 3, France, Cryopal has established itself as a key player in its markets through the quality of its equipment, services, and the professionalism of its teams. The company continues to grow in Europe and internationally, driven by its commitment to innovation and excellence.

Cryopal's extensive experience in liquid oxygen therapy and cryopreservation has positioned it as a trusted partner for healthcare providers and research institutions. The company's products are designed to improve patient outcomes and support scientific advancements in various fields. Cryopal's dedication to quality and customer satisfaction has earned it a reputation for reliability and expertise.

The company's strategic focus on innovation and operational excellence ensures that it remains at the forefront of its industry. Cryopal's commitment to continuous improvement and its ability to adapt to changing market needs make it a valuable partner for organizations seeking reliable and advanced solutions in liquid oxygen therapy and cryopreservation.

Connect with CRYOPAL

Why Contact CRYOPAL?

B2B professionals would contact Cryopal for its innovative and reliable solutions in liquid oxygen therapy and cryopreservation. The company's extensive experience and commitment to quality make it an ideal partner for healthcare providers and research institutions seeking advanced and dependable products.

Who Should Contact CRYOPAL for Business?

Sales teams selling medical equipment, healthcare providers, research institutions, and pharmaceutical companies should reach out to Cryopal. Recruiters seeking roles in healthcare technology and medical research should also consider Cryopal.

Categories

  • liquid oxygen therapy
  • cryopreservation
  • healthcare solutions
  • medical research
  • pharmaceutical industry
  • genetics
  • animal health
  • innovative products
  • quality equipment
  • customer satisfaction

More Healthcare Technology Companies

Frequently Asked Questions

How many employees does CRYOPAL have?
CRYOPAL has approximately 81 employees.
Where is CRYOPAL headquartered?
Marne La Vallee Cedex 3, France
What industry is CRYOPAL in?
CRYOPAL operates in Healthcare Technology, Medical Research, Pharmaceutical Industry.
When was CRYOPAL founded?
CRYOPAL was founded in 1968.
Is CRYOPAL still active?
Yes, CRYOPAL was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to CRYOPAL?
Research CRYOPAL's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.

Ready to Sell to CRYOPAL?

Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.

Discover Similar Companies
Find Decision Makers
Outreach Monitoring

View pricing · FAQs · Contact us

Last verified: February 2, 2026

Backed by startup programs from